| Execution period | 2 years |
|---|
BSE filing, NSE: ELIXIR. Summary written from the filing by ALFA Finder's alert engine.
Elixir Capital Ltd: key numbers
- Share price
- ₹91.84
- Market cap
- ₹53.30 Cr
- Revenue (annual)
- ₹34.21 Cr
- Net profit (annual)
- ₹3.03 Cr
- P/E (TTM)
- 8.3×Sector 19.7×
- Promoter holding
- 71.17%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Elixir Capital Ltd
All →Elixir Capital Other Announcement
Elixir Capital Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Elixir Capital Management Change
Elixir Capital Ltd has appointed M. Parashar & Co. as its new Statutory Auditor, replacing JMT & Associates upon the completion of their tenure.
Elixir Capital Other Announcement
Elixir Capital Ltd appointed M/s. M. Parashar & Co. as statutory auditors. This follows the completion of the previous auditors' term at the 32nd Annual General Meeting.
Elixir Capital Annual General Meeting
Elixir Capital held its 32nd AGM on August 25, 2026, approving financial statements, director re-appointments, and a dividend of Rs. 1.25 per equity share.
Elixir Capital Q1 FY27 Results: Net Profit ₹6.1 Cr, Up 125.9% YoY
Elixir Capital Ltd reported revenue from operations of ₹20.4 Cr (+87.2% YoY) and net profit of ₹6.1 Cr (+125.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹6.1 Cr · +125.9% YoY
Elixir Capital Board Meeting Date
Elixir Capital Ltd scheduled a board meeting for August 13, 2026, to approve financial results for the quarter ended June 30, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date